What is Royalty Pharma's financing cash flow?

Royalty Pharma (RPRX) reported financing cash flow of -$272.67M in Q1 2026.

How has Royalty Pharma's financing cash flow changed year-over-year?

Royalty Pharma's financing cash flow increased by 71.0% year-over-year, from -$941.3M to -$272.67M.

What does financing cash flow mean?

Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.

Royalty Pharma RPRX Financing Cash Flow

Financing Cash Flow at other companies

Ligand PharmaceuticalsLGND

-$14.13M-198%

BridgeBio PharmaBBIO

$549.89M+812%

Rigel PharmaceuticalsRIGL

-$10.92M-2,356%

Roivant SciencesROIV

$328.19M+220%

ALN

Alnylam PharmaceuticalsALNY

$36.24M-32.6%

Ionis PharmaceuticalsIONS

-$412.29M-33,163%

Other financials

Income statement

See full

Revenue$630.6M+11.0%

Operating income$563.0M+5.4%

Net income$294.7M+23.1%

EPS (diluted)$0.67+21.8%

Balance sheet

See full

Cash & equivalents$586.4M-46.1%

Total debt$9.0B+17.8%

Total equity$9.9B+1.6%

Total assets$19.8B+12.5%

Cash flow

See full

Operating cash flow$718.2M+20.5%

Valuation

See full

Market cap$26.58B+69.3%

Enterprise value$34.97B+51.4%

P/E32.1×+16.8×

P/S10.9×+4.1×

Profitability

See full

Operating margin65.1%-18.9pp

Net margin33.9%-14.4pp

Returns & leverage

See full

Return on equity8.4%-2.7pp

Debt / equity0.9×+0.1×

Current ratio2.7×+1.1×

Where this comes from

Reported directly by Royalty Pharma in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.

The official record: Royalty Pharma’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Royalty Pharma's financing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Royalty Pharma's financing cash flow?: Royalty Pharma (RPRX) reported financing cash flow of -$272.67M in Q1 2026.
How has Royalty Pharma's financing cash flow changed year-over-year?: Royalty Pharma's financing cash flow increased by 71.0% year-over-year, from -$941.3M to -$272.67M.
What does financing cash flow mean?: Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.